These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35814873)

  • 1. Application of the Indian Academy of Cytologists Recommendations for Reporting Serous Fluid Cytopathology in Routine Reporting of Ascitic Fluid Specimen and Assessment of the Risk of Malignancy.
    Jha S; Sethy M; Adhya AK
    J Cytol; 2022; 39(2):72-77. PubMed ID: 35814873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Indian Academy of Cytologists Guidelines for Reporting Serous Effusions: An Institutional Experience.
    Kundu R; Srinivasan R; Dey P; Gupta N; Gupta P; Rohilla M; Gupta S; Bal A; Rajwanshi A
    J Cytol; 2021; 38(1):1-7. PubMed ID: 33935385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
    Kolte S; Zaheer S; Aden D; Ranga S
    Cytojournal; 2022; 19():52. PubMed ID: 36128470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.
    Kala C; Kala S; Singh A; Jauhari RK; Bajpai A; Khan L
    J Cytol; 2023; 40(4):159-164. PubMed ID: 38058672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
    Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
    Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
    Jha S; Sethy M; Adhya AK
    Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
    Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
    J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Fine Needle Aspiration Biopsy Cytology Using the Newly Proposed IAC Yokohama System for Reporting Breast Cytopathology: The Experience of a Single Institution.
    Montezuma D; Malheiros D; Schmitt FC
    Acta Cytol; 2019 Feb; ():1-6. PubMed ID: 30783035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification of Breast Fine-Needle Aspiration Biopsy Specimens Performed without Radiologic Guidance by Application of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Cytopathology.
    Sarangi S; Rao M; Elhence PA; Nalwa A; Bharti JN; Khera S; Vedant D; Vishwajeet V; Vishnoi JR; Sharma N; Pareek P
    Acta Cytol; 2021; 65(6):483-493. PubMed ID: 34535580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".
    Kapoor S; Samanta S; Kaur K
    J Cytol; 2024; 41(2):96-104. PubMed ID: 38779601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology-A study on gynaecological samples.
    Rakheja G; Singh M; Priyadarshnee B; Marimuthu B; Dhar L; Jain S; Khurana N; Rathore A
    Cytopathology; 2023 Mar; 34(2):138-145. PubMed ID: 36530023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Indian Academy of Cytologists Guidelines for Reporting Serous Effusion (IACGRSE): An Interobserver Agreement Analysis.
    Nagose VB; Kamal MM; Kathuria SS; Laddhad SA
    J Cytol; 2022; 39(3):121-125. PubMed ID: 36277801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectuation of International Academy of Cytology Yokahama Reporting System of Breast Cytology to Assess Malignancy Risk and Accuracy.
    Tejeswini V; Chaitra B; Renuka IV; Laxmi K; Ramya P; Sowjanya KKS
    J Cytol; 2021; 38(2):69-73. PubMed ID: 34321772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
    Wang M; Sun T; Jiao J; Wang H
    Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
    Pergaris A; Stefanou D; Keramari P; Sousouris S; Kavantzas N; Gogas H; Mikou P
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.
    Bharti S; Nalwa A; Elhence PA; Rao M; Bharti JN; Khera S; Vedant D; Vishwajeet V; Goel A
    Acta Cytol; 2022; 66(5):449-456. PubMed ID: 35413720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
    Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
    Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Malignancy in Effusions according to the International System for Serous Fluid Cytopathology: A Review.
    Castilho da Silva DJ; Dos Santos CR; Xavier-Júnior JCC
    Acta Cytol; 2024; 68(4):384-393. PubMed ID: 39025059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of 512 cases of breast fine needle aspiration cytology utilizing the recently proposed IAC Yokohama system for reporting breast cytopathology.
    Dixit N; Trivedi S; Bansal VK
    Diagn Cytopathol; 2021 Sep; 49(9):1022-1031. PubMed ID: 34133084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Male Breast Lesions According to the IAC Yokohama System for Reporting Breast Cytopathology.
    Oosthuizen M; Razack R; Edge J; Schubert PT
    Acta Cytol; 2021; 65(2):132-139. PubMed ID: 33333512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.